SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 89.30 |
| Enterprise Value ($M) | 94.64 |
| Book Value ($M) | -6.51 |
| Book Value / Share | -0.84 |
| Price / Book | -13.71 |
| NCAV ($M) | -13.11 |
| NCAV / Share | -1.69 |
| Price / NCAV | -6.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.19 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.01 |
| Current Ratio | 0.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.06 |
| Assets | 6.66 |
| Liabilities | 13.17 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bank Of Nova Scotia | 2.40 | ||
| 13G | Harraden Circle Investments, LLC | 5.20 | ||
| 13G/A | Glazer Capital, Llc | 0.34 | -98.63 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| PAHC – Phibro Animal Health Corporation | PROC – Procaps Group S.A. |
| PTGX – Protagonist Therapeutics, Inc. | QTTB – Q32 Bio Inc. |
| RANI – Rani Therapeutics Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io